Mitzi Solomon, founder and president of Countdown, an Atlanta-based nonprofit advancing mitochondrial science and medicine. (Photo courtesy of Countdown)

Every heartbeat, every thought and every movement depend on something most people haven’t considered since eighth-grade biology: mitochondria.

Atlanta-based nonprofit Countdown is bringing these tiny cellular structures into the spotlight, funding research and connecting scientists, philanthropists and health care leaders to explore how mitochondrial health could change disease detection, prevention and treatment.

For founder and President Mitzi Solomon, the mission began with a lifetime of health challenges.

“I’ve had a lifetime of complex health challenges since I was born, all the way through being an adult,” Solomon said.

Navigating those challenges and advocating for her children’s health forced Solomon to become what she calls the “CEO of my own health.”

She described struggling to find answers in a medical system that often treated individual symptoms and organs rather than examining how the body functions as a whole. Her experience, combined with having a cousin with a rare primary mitochondrial disease, prompted her to investigate mitochondrial science.

The more she learned, the more she wondered why something so fundamental to human health wasn’t receiving greater attention.

Mitochondria are structures inside cells that convert nutrients and oxygen into usable energy. Often called the powerhouses of the cell, they also help regulate metabolism, immune responses and cellular communication.

When mitochondria malfunction, the effects can extend throughout the body, particularly in energy-demanding organs such as the brain, heart and muscles.

Primary mitochondrial diseases result from genetic defects that directly impair mitochondrial function. Secondary mitochondrial dysfunction occurs when other diseases, aging or other factors disrupt how mitochondria operate.

A 2020 editorial in the scientific journal Cells reviewed 24 scientific articles examining how mitochondrial dysfunction is connected to diseases including cancer, diabetes and neurological disorders. The authors highlighted how disruptions in cellular energy production, oxidative stress and the processes that regulate cell survival and death may contribute to tissue damage and disease progression. However, researchers are still working to understand these connections and how they could lead to effective treatments.

Countdown also points to potential links with Alzheimer’s disease, Parkinson’s disease, autism and cerebral palsy, suggesting that advances in mitochondrial research could have implications for a wide range of health conditions.

For Solomon, that uncertainty underscores the importance of further research.

“At its heart, it’s really about the families looking for answers and researchers working to find them,” Solomon said.

The organization’s name reflects that urgency.

“Countdown reflects a sense of urgency and the belief that time matters for families waiting for answers and researchers pursuing promising discoveries,” she said.

Countdown reports raising more than $3.5 million and directing more than $2.2 million toward research over three years.

Its initiatives include blood-based biomarkers being developed with Minovia Therapeutics to assess mitochondrial function and experimental mitochondrial transplantation research led by James D. McCully through Harvard Medical School and Boston Children’s Hospital.

The transplantation project investigates whether introducing healthy mitochondria could help preserve muscle function in Duchenne muscular dystrophy, a genetic disorder causing progressive muscle weakness. The potential benefits require further testing.

According to Countdown, mitochondrial science has historically received less than 1% of philanthropic research funding.

Julie Teer, Countdown’s CEO and former Wellstar Foundation president, hopes to expand that investment through research partnerships, fundraising and public education.

“We’re focused on funding bold, high reward research that traditional funding often leaves behind,” Teer said.

Julie Teer, CEO of Countdown and former president of the Wellstar Foundation, leads the nonprofit’s growth and research partnerships. (Photo courtesy of Countdown.)

Countdown also encourages everyday attention to cellular health. Solomon emphasizes exercise, nutrition and stress management, while Teer highlights adequate sleep.

The nonprofit will host its Evening of Energy gala Jan. 30, 2027, in Atlanta, bringing together scientists, business leaders and philanthropists to support its mission.

Teer hopes that collaboration will help position Atlanta as a leader in the field.

“Our goal is that Countdown will help Atlanta become a national hub for advancing mitochondrial science in medicine,” she said.

For Solomon, success ultimately means families receiving answers sooner and patients having better treatment options.

For those waiting on medical breakthroughs, every moment counts.

Gabi Hart is a contributor to SaportaReport and was a member of the inaugural cohort of interns for Atlanta Way 2.0 and SaportaReport during the summer of 2025. She earned a Master of Urban Studies degree...

Leave a comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.